SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?


To: LORD ERNIE who wrote (750)6/8/2000 9:39:00 AM
From: StockDung  Respond to of 857
 
Asensio Wins Against Hemispherx


NEW YORK, June 8 /PRNewswire/ -- The following is being issued by Asensio & Company, a member of the National Association of Securities Dealers, CRD number 31742:

Yesterday, United States District Court Judge John R. Padova entered an Order granting in full Asensio & Company, Inc.'s ("Asensio") Motion to Dismiss. Judge Padova further ordered that all pending motions are dismissed and that Hemispherx Biopharma, Inc.'s (Amex: HEB) case against Asensio is closed.

Hemispherx is a Stratton Oakmont stock fraud controlled by William A. Carter who has been charged with medical and scientific fraud and is being investigated for stock fraud. Since September 30, 1998, Hemispherx has used the legal services of Michael A. Walsh and David C. Franceski to harass Asensio, its employees and clients. The purpose of this harassment was to attempt to discredit and silence Asensio. Asensio was not discouraged and actively followed HEB even while the action was pending. The most recent example is on March 17, 2000 when Asensio reported that Hemispherx had issued misleading HIV treatment reports that had caused HEB's shares to trade as high as $19.

Asensio is an institutional investment bank specializing in corporate valuations and equity research. Asensio also specializes in investigating and short selling stock promotions and publishing research on companies it identifies as grossly overvalued. A complete documented history of Asensio's published work with overly promoted securities, and the firm's definition of gross overvaluation, is available at asensio.com. Asensio was recently the target of six lawsuits by the subjects of Asensio's research reports. After the Asensio reports, these companies' stocks declined by an average of 88% after the Asensio reports. All six lawsuits have now been dismissed. Asensio has never retracted any statement or paid any amount to settle any of these suits.

This report should not be construed as an offer to sell or solicitation of an offer to buy any securities. Opinions expressed are subject to change without notice. This report has been prepared from original sources and data which we believe to be reliable but accuracy is not guaranteed. This research report was prepared by Asensio & Company, Inc. whose stockholders, officers and employees may from time to time acquire, hold or sell a position in the securities mentioned herein. Asensio & Company, Inc. may act as principal for its own account or may sell or buy to or from its customers the securities described herein. Asensio & Company, Inc., may from time to time perform investment banking or other services for, or solicit investment banking or other business from, any company mentioned in this report or its affiliates.

SOURCE Asensio & Company, Inc.

CO: Asensio & Company, Inc.; Hemispherx Biopharma, Inc.

ST: New York, Pennsylvania

IN: FIN MTC

SU: LAW

06/08/2000 09:11 EDT prnewswire.com



To: LORD ERNIE who wrote (750)6/22/2000 8:39:00 AM
From: LORD ERNIE  Read Replies (1) | Respond to of 857
 
Hemispherx Biopharma Retains Anderson Clinical Research to Initiate Phase 2/3 Trials in HIV Disease

PHILADELPHIA, Jun 20, 2000 /PRNewswire via COMTEX/ -- Hemispherx Biopharma,
Inc. (Amex: HEB; HEBws) said it has retained the services of Anderson Clinical
Research, Inc. ("Anderson") with respect to design and implementation of its
Phase 2/3 trials in HIV disease. Anderson is one of the leading Clinical
Research Organizations (CRO) specializing in innovative HIV research.

Anderson Clinical Research, Inc., which is based in Pittsburgh, PA, is
world-recognized for conducting expedited clinical trials in AIDS which
thereafter become the basis for full drug marketing authorizations. Anderson has
operated AIDS-related clinical trials for most of the multinational
pharmaceutical companies involved in advanced AIDS treatments. Eight major
metropolitan locations in the U.S., plus four treatment sites in New York City,
are utilized as core referral centers. Anderson has conducted many successful
Phase 2, 3 and 4 (post-marketing approval) clinical programs on the panel of
fourteen antivirals which are the present foundation for AIDS treatment.

"We are very excited about the prospects for Ampligen(R) to fill a major void in
our overall therapeutic approach to HIV," said Roger Anderson, M.D., Chief
Executive Officer and President of Anderson Clinical Research, Inc.

Hemispherx said that the new clinical rationale and new ex vivo data, underlying
the new treatment program, would be presented by the Medical Directors of
Anderson at the upcoming July, 2000, International AIDS Conference in Durban,
South Africa. The AIDS conference organizers expect attendance in the thousands
by researchers, physicians, advocacy groups and media science writers, each
representing various parts of the world affected by the global epidemic.

Information contained in this news release other than historical information,
should be considered forward-looking and is subject to various risk factors and
uncertainties. For instance, the strategies and operations of Hemispherx involve
risks of competition, changing market conditions, changes in laws and
regulations affecting these industries and numerous other factors discussed in
this release and in the Company's filings with the Securities and Exchange
Commission. Accordingly, actual results may differ materially from those in any
forward-looking statements.

SOURCE Hemispherx Biopharma, Inc.

CONTACT: William A. Carter, M.D., CEO & Chairman, 215-988-0080, or
 Dianne Will, Investor Relations, 214-954-9300, fax, 214-954-9333, both of
 Hemispherx Biopharma; or Mark Kollar, Institutional Investors of Broadgate,
 212-232-2222, fax, 212-232-3232, for Hemispherx; or Roger Anderson, M.D. of
 Anderson Clinical Research, 412-247-2285

URL: hemispherx.com



To: LORD ERNIE who wrote (750)7/7/2000 9:39:31 PM
From: StockDung  Read Replies (1) | Respond to of 857
 
Yet another stock promoter tied to Hemispherx.
businessweek.com

Heading the list of heavily shorted stocks that Dirks's crew is defending: Organogenesis (ORG), which plummeted from 37 in late April to 12 5/8, and Hemispherx BioPharma (HEB), which fell from 12 1/2 on Sept. 9 to 5 on Sept. 25. Hemispherx is now back above 8.
===================================================

Yet another fraudulent stock promoter tied to Hemispherx.

Rafi M. Khan, a stockbroker who has been charged with stock manipulation by the Securities and Exchange Commission ("SEC"), has been tied to Hemispherx Biopharma, Inc. (AMEX: HEB). In a July 30, 1998 complaint, the SEC charged Mr. Khan with manipulating share prices in two companies. Mr. Khan allegedly conducted his illegal stock promotion while operating the one-person Southern California office of Shamrock Partners, Ltd. ("Shamrock"). According to an NASD Public Disclosure statement, Mr. Khan was employed by Shamrock from October 24, 1994 until December 30, 1996.

In an SEC Form 424B3 dated September 30, 1996, Hemispherx disclosed that it had entered into a consulting agreement with Shamrock in August 1996 wherein Hemispherx granted Shamrock an option to purchase 600,000 shares of HEB stock during the five-year period beginning August 15, 1996, at an exercise price of $2.50 per share. In an SEC filing dated February 25, 1998, Hemispherx registered 600,000 shares for Shamrock. These 600,000 shares represented shares of common stock underlying warrants exercisable through August 15, 2001 at $2.50 per share. Hemispherx paid for the cost of registration, which would allow Shamrock to sell its privately obtained, cheap, insider shares to the public without further notice or disclosure.

Mr. Khan joins a group of fraudulent stock promoters associated with Hemispherx that includes Stratton Oakmont, Inc., which was in December 1996 expelled from the NASD; Stratton’s former chairman, Jordan Belfort, who in September 1998 was indicted and charged with conspiracy, fraud, money laundering and obstruction; and Monroe Parker Securities, Inc., which was in October 1998 named as a defendant in a New York State Attorney General ("NYSAG") stock-manipulation indictment.

There are numerous other promoters tied to Hemispherx, including Harris Freedman and Sharon Will, who have been vice presidents of Hemispherx since 1994, and a former Hemispherx board member, Stephen J. Drescher. These three have all been associated with three of the companies, including Hemispherx, named in a press release announcing the NYSAG indictment. Among other HEB stock promoters are David C. Drescher, who is related to Stephen Drescher and is the president of Millenium International Communications, Ltd., and Value Management & Research AG ("VMR"), which has released a series of Hemispherx research reports, including one dated April 26, 1999 that made false Ampligen HIV efficacy claims. On April 13, 1999, Hemispherx filed a registration statement with the SEC to allow VMR to sell 750,000 HEB shares plus 250,000 shares underlying warrants.

Further details of the fraudulent VMR report and the involvement of HEB officers in other manipulated stocks can be found here. Ever since its 1995 IPO, Hemispherx has regularly granted options and registered new shares for individuals and entities proved to be stock promoters. This in turn has created the incentive for Hemispherx’s continual, fraudulent stock promotion.



To: LORD ERNIE who wrote (750)4/11/2003 2:16:26 PM
From: StockDung  Respond to of 857
 
RE:Cowen/Rafi Khan->***Medinah's Price a key target in Bermuda Short***

2002-08-22 10:10 PT - Street Wire

by Brent Mudry

Veteran North Vancouver penny stock promoter ***Les Price***, one of numerous Howe Street figures busted in Operation Bermuda Short last week, may prove to be one of the most interesting figures to U.S. and Canadian authorities. ***Mr. Price*** is the key bridge player, the only one of 58 individuals indicted in the overall three-year FBI-RCMP joint undercover operation known to have had pertinent direct dealings with targets in both phases of the probe: the bribed mutual fund manager sting and the money laundering sting.

***Mr. Price***, 64, was arrested and charged last week with securities fraud in relation to his pink-sheets promotion, ***Medinah Minerals***, in one of 20 grand jury indictments naming 52 individuals, including 14 Canadians, in the greased fund manager operation. The Howe Street promoter, currently in custody in Miami, is expected to face a bail hearing Monday. All parties remain presumed innocent until proven guilty.

The money laundering sting was smaller, featuring five Canadians among six targets in three overlapping grand jury indictments. While the bribery sting targets featured a mix of Vancouver and Toronto penny stock players, all five Canadians in the money laundering case are players on Howe Street, the centre of dealings for the former Vancouver Stock Exchange, dubbed Scam Capital of the World by Joe Queenan in Forbes magazine over a decade ago.

The alleged money launderers include controversial former lawyer Martin Chambers, who beat a Miami-Vancouver cocaine importation rap two decades ago, Kevan Garner and his partner John Kenneth (Jack) Purdy, and forestry entrepreneurs Ronaldo (Ron) Horvat and Harold A. Joliffe. Hours after a Stockwatch article Tuesday, Mr. Purdy, a key director, major shareholder and spokesman of Vertigo Software, a TSX Venture Exchange promotion of Howe Street promoter Don Sheldon, publicly resigned from the company's board.

While ***Mr. Price*** is not mentioned in any of the three money laundering indictments, he recently had direct dealings with one of the targets, Mr. Jolliffe. In September, 2000, while the RCMP end of the undercover operation was in full swing, one of ***Mr. Price's*** OTC Bulletin Board companies, NP Energy Corp., acquired a major interest in Bolivian Hardwood Corp., the only company noted in the money laundering indictments, and named Hardwood principal Mr. Jolliffe to NP Energy's board.

There is no suggestion, of course, that ***Mr. Price*** had any involvement or any knowledge whatsoever of any drug money laundering operations. His dealings with Mr. Jolliffe, however, place him in a rather unique situation. If ***Mr. Price*** chooses to co-operate with authorities and provide helpful information on players in both phases of the Bermuda Short sting, he may be able to leverage his hand and win a sweeter deal than any others who decide to flip. While few of the arrested Howe Street figures are young spring chickens, ***Mr. Price***, at age 64, may be quite motivated to avoid spending the rest of his life in prison if his lawyers discover the U.S. has a strong case against him.

***PRICE UNLUCKY WITH SHAMROCK***

***Mr. Price*** had the misfortune of picking a notorious U.S. brokerage when he tried lining up a $5-million financing for his ***Medinah Minerals***, allegedly by planning a $1.5-million bribe for an undercover FBI special agent posing as a dirty mutual fund manager. (All figures are in U.S. dollars.) ***Mr. Price*** picked Shamrock Partners of Media, Pa., a house well known to authorities. (Shamrock also served as one of 13 market makers for ***Mr. Price's*** other promotion, NP Energy.)

Shamrock is best known for its star former broker, Rafi Mohamad Khan, a close former associate of notorious boiler-room operator Irving Kott, the prime target of a high-profile, multi-year United States Securities and Exchange Commission investigation leading right to Howe Street. Mr. Khan flipped to become a star witness for the U.S. Department of Justice in the fall of 1998.

Shamrock figures are named in two of the 23 federal grand jury indictments unsealed recently in United States District Court for the Southern District of Florida. The first, relating to ***Medinah***, names ***Mr. Price and Joseph R. (Joe) Huard***, one of the founders and officers of Shamrock. The second, relating to another penny stock deal, Lighthouse Fast Ferry Inc., names ***Mr. Huard***, its owner James T. (Jim) Kelly and close associate Bruce D. Cowen, the chairman and chief executive officer of Capital Research Ltd., of San Juan Capistrano, Calif., the home of the famous swallows. While the shamrock may be a good-luck charm for Irish folks like Mr. Kelly, the proverbial birds are now coming home to roost.

Operation Bermuda Short is just the latest setback for the folks at Shamrock. In April, 2001, the SEC fined the brokerage and three key aiders and abettors of Mr. Khan's 1995 rig job of L.L. Knickerbocker, Mr. Kelly and two traders, a total of $85,000. Mr. Kelly was given a six-month ban on acting in any supervisory capacity with any brokerage, while the two traders were fined $5,000 and banned for three months each.

The Knickerbocker settlements came 10 months after Mr. Khan agreed to a five-year brokerage ban for his egregious rig jobs of Knickerbocker in 1995 and Future Communications in 1993. The controversial former broker and penny stock promoter was not fined a penny for either rig job, a measure of just how valuable he is to federal officials.

Mr. Kelly also had the misfortune of running afoul of regulators a few years before his Knickerbocker settlement. On Nov. 12, 1998, the SEC found that Shamrock Partners and Mr. Kelly violated the National Association of Securities Dealers' Rules of Fair Practice by charging clients excessive markdowns. The SEC supported a joint fine of $15,000 against Shamrock and Mr. Kelly, plus restitution of $10,053 and payment of hearing costs. In the NASD prosecution of this case, Mr. Price's current co-accused, ***Mr. Huard***, gave testimony, although the Shamrock executive vice-president and financial officer was not charged himself.

Shamrock also emerged as a key conduit in an unrelated but much more serious criminal penny stock case. The Pennsylvania-based brokerage was one of a small handful of firms used by a notable stock fraud ring to service nominee accounts. Las Vegas penny-stock shell engineer Robert E. Potter and his partner Peter E. Berney, key associates of career Vancouver fraudster Michael Mitton in the H & R Enterprises scandal, were prime players in this ring of mob-linked penny-stock promoters which used extortion, threats and violence to coerce brokers and co-conspirators to keep them in line, according to several U.S. indictments.

In one case, Herbert Jacobi, the Las Vegas pair's New York attorney, who also served Mr. Mitton in the H & R affair and helped the now-jailed Canadian wire H & R proceeds to Panama, risked his fine penny-stock legal career by allegedly buying stolen FBI records in a blundering bid to check the status of a New York prosecution against Mr. Potter.

In another case, broadly spanning from November, 1995, or April, 1996, through November, 1998, New York-area defendants Peter Liounis, Christian Rizzo, Walter Culkin, Vladimir "Vinny" Shtutman (also known as Vinny Shtuts), Oleg "Alex" Feldman and Shaun Neal flogged Sports Vision and Surequest shares from a boiler-room office in Manhattan. The ring allegedly received more than $8-million from the sale of Sports Vision shares and more than $2-million from the sale of Surequest shares through nominee accounts at Shamrock and a few other image-challenged brokerages.

In one of the scariest encounters, Mr. Rizzuto, Mr. Liounis, Mr. Culkin and Mr. Rizzo confronted one co-conspirator at the MGM Hotel and Casino in Las Vegas on Jan. 9, 1998, and after receiving $2,000 in cash, demanded another $100,000 on the following Monday and a further $250,000 on the following Wednesday. The fearsome foursome allegedly directly and indirectly threatened to harm members of the conspiracy if their payment demands were not met.

The shadow of Mr. Khan also lurked over Shamrock in several other cases in recent years. In 1998, Nancy Martin, the manager of a Shamrock branch office in Newport Beach, Calif., was fined $20,000 and banned for any association with any brokerage in any capacity. Ms. Martin was disciplined for failing to supervise broker Tariq Khan, Rafi Khan's nephew, although she claimed on appeal that the younger Khan was the president of the company that owned Shamrock.

***PRICE STUNG IN PENNY STOCK BRIBERY SCHEME***

Against this backdrop of shady Shamrock dealings, U.S. authorities claim Howe Street promoter ***Mr. Price*** began working on a Medinah kickback financing last fall. The alleged conspiracy covers the period from October, 2001, to this June.

***Mr. Price and Shamrock's Mr. Huard*** allegedly conspired to bribe an undercover FBI agent, posing as a fund manager, to buy five million shares of Medinah for $5-million, or $1 a share, at a time when the stock was trading at just six cents. "Defendant ***LES PRICE*** agreed to pay undisclosed kickbacks to the UCA and others at the fund so that they would violate their fiduciary obligations by purchasing a large amount of overpriced MDMN stock with the fund's money," states the grand jury indictment.

"Defendant ***LES PRICE*** agreed to pay approximately 30% of the $5,000,000 purchase price as an undisclosed kickback to defendant ***JOSEPH R. HUARD JR***., the UCA (the undercover FBI agent,) CWs (unidentified 'co-operating witnesses' posing as dirty fund officials) and a purported corrupt manager of the fund to induce the fund to purchase approximately $5,000,000 of overprice MDMN stock rather than shares of another company's stock."

In a covertly recorded Oct. 17, 2001, call, ***Mr. Price*** advised the undercover agent and the co-operating witnesses that another Medinah official would meet them in Florida to discuss the big financing, but the officer was "not really intimate on how these things work." In another call six weeks later, on Nov. 30, 2001, ***Mr. Huard*** chatted with the undercover federal operatives about the stock purchase-kickback scheme, including when ***Mr. Price*** would fly down from Vancouver to Miami to meet them in person.

Things were apparently going so well that ***Mr. Price*** felt emboldened to issue a false Medinah press release on Jan. 31 announcing thee "signed completion" of a $5-million financing package. "The first deposit of moneys, memorializing the framework of the funding deal, have been received into the Medinah Minerals, Inc. bank account." The Howe Street promoter forgot to mention this first deposit was a test trade of 25,000 shares for $25,000, complete with an alleged $9,980 kickback wired that same day from Medinah's bank account in Vancouver to the undercover FBI agent's bank account in Miami. (This kickback wire earned ***Mr. Price a charge of money laundering.)***

"When Medinah Minerals, Inc. is released from its Non-Disclosure Agreement mandates, Management will identify the funding party. The balance of the entire five million dollar ($5 million) funding package is scheduled to be received by Medinah Minerals, Inc. over the course of the next three business week," stated the company in its press release.

A month later, ***Mr. Price*** was still confident even though no more of the $5-million financing had materialized. "On or about February 26, 2002, during an international telephone call, defendant ***LES PRICE*** told the CWs that the 'deal's still on. You just gotta sort out your marketing team.'"

The big financing mysteriously flopped and a grand jury subsequently handed down a grand jury indictment on July 25 charging ***Mr. Price and Mr. Huard*** with a total of 14 counts.

Unbeknownst to the targets, a Miami grand jury handed down another indictment two months earlier, on May 28. This indictment, involving a similar bribery scheme for Lighthouse Fast Ferry, named ***Mr. Huard***, Shamrock owner Mr. Kelly and their close associate Mr. Cowen. Mr. Cowen served as purported chairman of Capital Research Ltd., which shared Shamrock's address in Media, and as managing director of The Lancer Group, a purported hedge fund based on Wall Street.

Shamrock's Mr. Kelly and Capital's Mr. Cowen were apparently quite close. "Jim Kelly, my partner and I have developed this comprehensive proposal ... we are a results-driven firm," stated Mr. Cowen in a 1999 engagement letter for another bulletin board client, Total Film Group. "Jim's firm, Shamrock Partners, is currently a market maker in your stock," Mr. Cowen reminded Total Film.

The aura of Rafi Khan lingers on. In recent years, Capital Research has also been involved with Aura Systems, Symposium Telecom and Lighthouse Fast Ferry, which feature similar players and offshore flavours with Total Film.

On April 3, the SEC revealed it is investigating whether Mr. Khan used a Pakistani holding company and his wife, Rubina Khan, to trade shares of four companies: Aura, Ontro Inc., Adnan Khashoggi's GenesisIntermedia Inc. and eUniverse Inc., in contravention of a market ban imposed two years ago. According to court filings, the Khan family holding company, Aura Private Ltd., or Aura Pvt. in short, traded through brokerage accounts in Canada, as well as the U.S.

(The current SEC investigation is especially unfortunate for Aura Systems, as the company has been rebuilding its reputation and credibility in the wake of an SEC accounting and auditing prosecution in 1996. The SEC charged Aura, chief executive and chairman Zvi Kurtzman, and accountants Francis T. Phalen and Joseph Bevacqua with boosting Aura's 1993 and 1994 revenues by 22 per cent and 11 per cent, respectively, through booking a bogus transaction with a company called John Jory Co. In June, 2001, Mr. Kurtzman, who headed Aura since 1987 and remains its CEO and chairman, joined the board of Ontro.)

Large blocks of one Khan promotion, Aura Systems, are held at Vancouver-based Canaccord Capital and Toronto-based CIBC World Markets, according to regulatory filings, although there is no allegation these clients were involved in, or even aware of, Mr. Khan's activities.

Regulatory filings also show that Mr. Khan's nephew, Tariq Khan, served as president of Ontro in 1998. The young Khan, as noted above, is also a graduate of Shamrock, like his uncle Rafi Khan.

PRICE AND HARDWOODS

The three Bermuda Short drug money laundering indictments target long-time Howe Street promoter Mr. Purdy, his partner Mr. Garner, former lawyer Mr. Chambers, forestry associates Mr. Horvat and Mr. Jolliffee, and Bahamian accountant Michael Hepburn.

One indictment leads off with Bolivian Hardwood, a private company engaged in harvesting timber in Bolivian. Mr. Jolliffe is described as a principal of Bolivian Hardwood, while Mr. Horvat is described as a corporate officer. Howe Street promoter Mr. Purdy is also described in the Bermuda Short indictment as a principal of Bolivian Hardwood.

In one of the intriguing coincidences of the overall case, NP Energy, one of Mr. Price's public companies, acquired a 10-per-cent stake in Bolivian Hardwood in September, 2000, with an option to acquire an additional 39-per-cent stake.

"NP Energy Corporation plans to raise several million dollars in order to expand operations of Bolivian Hardwood to further develop markets for the lumber produced and to substantially increase the company's timber acreage position in Bolivia," stated the company in its release.

"The Directors of NP Energy Corporation are also pleased to announce that Mr. Harold Jolliffe has joined the board of directors of the company. Mr. Jolliffe is currently one of the principals in Bolivian Hardwood Corporation and has decades of experience in all aspects of forestry, logging and saw milling. Mr. Jolliffe previously held important educational posts with forestry departments in British Columbia's leading secondary education institutions."

"Management of NP Energy Corporation firmly believes that the acquisition of this interest in Bolivian Hardwood Corporation and the addition of Mr. Harold Jolliffe to the board of directors, will quickly move the company forward following its recent reorganization that was approved at the Special Stockholder's Meeting May 22, 2000."